ACLA Expresses Serious Concerns with Proposed PAMA Medicare Payment Rates for Clinical Laboratory Tests


Write your Congressman to delay and fix PAMA Implementation


ACLA Writes CMS Administrator Verma on PAMA

Urging delay and fix to PAMA


ACLA Comments on Bucshon-DeGette Discussion Draft Impacting the Regulation of Clinical Laboratory Diagnostics

The Protecting Access to Medicare Act of 2014

Big changes are coming to how Medicare pays for clinical lab services – here’s everything your lab needs to know about the new law. 

Learn More »

ACLA 2017 Annual Meeting Photo Gallery


Learn about the benefits of joining the nation’s leading advocacy organization for clinical laboratories.


View all news & updates » Recent News & Updates

View all news & updates »

Policy Issues

  • Reimbursement and Coverage

    Medicare cuts to clinical labs threaten jobs, stifle innovation, and put patient access to vital lab tests at risk.

    Continue Reading »

  • Laboratory Developed Tests

    ACLA believes now is the appropriate time to develop a logical laboratory-developed test (LDT) framework that promotes innovation and advances patient care.

    Continue Reading »

  • IOAS Exception

    Self-referral leads to over-utilization, mistreated patients, and billions of wasted Medicare dollars. It’s time to close the loophole.

    Continue Reading »

View all policy issues »